Metraipolis › archive › dc_17cccb417992

Systemic lupus erythematosus: from an adverse event of interferon administration to a disease with new treatment options — Europe PMC PMID:41503065

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41503065
DOI: 10.48101/ujms.v130.13677
License (as archived): solo-consultazione
Archived: 2026-11-07T14:07:49.762Z
SHA-256 of the archived text: 5227482a96ea667b7bf89b5b0d47be56da28d65ef9fdf737e9b0163961fcec64
Stable URL of this page: https://metraipolis.com/documento/dc_17cccb417992

How to cite

Systemic lupus erythematosus: from an adverse event of interferon administration to a disease with new treatment options — Europe PMC PMID:41503065 — Europe PMC (en), https://europepmc.org/article/MED/41503065 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17cccb417992 (Metraipolis archive dc_17cccb417992, sha256 5227482a96ea667b7bf89b5b0d47be56da28d65ef9fdf737e9b0163961fcec64)

BibTeX

@misc{dc17cccb417992,
  title = {Systemic lupus erythematosus: from an adverse event of interferon administration to a disease with new treatment options — Europe PMC PMID:41503065},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41503065},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17cccb417992; sha256 5227482a96ea667b7bf89b5b0d47be56da28d65ef9fdf737e9b0163961fcec64},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41503065. Agents can read the archived copy with the MCP tool read_document.